Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Multicenter Phase ◽

Efficacy and Safety of 400 and 800 mg Etodolac vs. 1,000 mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial

Pain Practice ◽

10.1111/j.1533-2500.2012.00572.x ◽

2012 ◽

Vol 13 (3) ◽

pp. 191-197 ◽

Cited By ~ 5

Author(s):

Vesile Öztürk ◽

Mustafa Ertaş ◽

Betül Baykan ◽

Hadiye Şirin ◽

Aynur Özge ◽

...

Keyword(s):

Clinical Trial ◽

Acute Treatment ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Multicenter Phase

Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.10.009 ◽

2020 ◽

Vol 42 (12) ◽

pp. 2266-2279

Author(s):

Min-Kyung Lee ◽

Younghoon Jeon ◽

Sang Sik Choi ◽

Pyung Bok Lee ◽

Yong-Chul Kim ◽

...

Keyword(s):

Clinical Trial ◽

Neuropathic Pain ◽

Controlled Release ◽

Immediate Release ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial

Archives of Physical Medicine and Rehabilitation ◽

10.1016/j.apmr.2020.03.025 ◽

2020 ◽

Vol 101 (9) ◽

pp. 1485-1496

Author(s):

Junekyung Lee ◽

Min Ho Chun ◽

Young Jin Ko ◽

Shi-Uk Lee ◽

Deog Young Kim ◽

...

Keyword(s):

Clinical Trial ◽

Upper Limb ◽

Active Drug ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Multicenter Phase ◽

Limb Spasticity

Efficacy and safety of zoledronic acid in patients with moderate to severe pain induced by bone metastasis associated with solid tumor or multiple myeloma: A randomized, double-blind, multicenter phase III clinical trial

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.14679 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 14679-14679

Author(s):

M. Dong ◽

F. F. Yi

Keyword(s):

Clinical Trial ◽

Multiple Myeloma ◽

Zoledronic Acid ◽

Bone Metastasis ◽

Severe Pain ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Multicenter Phase

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2

Transplantation Journal ◽

10.1097/00007890-199807150-00005 ◽

1998 ◽

Vol 66 (1) ◽

pp. 29-37 ◽

Cited By ~ 217

Author(s):

A. Osama Gaber ◽

M. Roy First ◽

Raymond J. Tesi ◽

Robert S. Gaston ◽

Robert Mendez ◽

...

Keyword(s):

Clinical Trial ◽

Graft Rejection ◽

Phase Iii ◽

Double Blind ◽

Acute Graft Rejection ◽

Multicenter Phase ◽

Acute Graft

Abstract P3-12-07: A multicenter randomized double-blind phase III clinical trial to evaluate the efficacy and safety of GCPGC, a novel pegylated G-CSF in patients receiving DA or TAC chemotherapy for breast cancer compared to peg-filgrastim

10.1158/1538-7445.sabcs14-p3-12-07 ◽

2015 ◽

Author(s):

Joo Han Lim ◽

Ki-Hyeong Lee ◽

Keon-Uk Park ◽

In-Hae Park ◽

Eun Kyung Cho ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Tac Chemotherapy

Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study

Epilepsia ◽

10.1111/epi.13993 ◽

2018 ◽

Vol 59 (2) ◽

pp. 479-491 ◽

Cited By ~ 37

Author(s):

Eugen Trinka ◽

Elinor Ben-Menachem ◽

Pedro A. Kowacs ◽

Christian Elger ◽

Birgit Keller ◽

...

Keyword(s):

Controlled Release ◽

Multicenter Study ◽

Phase Iii ◽

Newly Diagnosed ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

A Multicenter, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Cell and Gene Therapy in Knee Osteoarthritis Patients

Human Gene Therapy Clinical Development ◽

10.1089/hum.2017.249 ◽

2018 ◽

Cited By ~ 1

Author(s):

Myung-Ku Kim ◽

Chul-Won Ha ◽

Yong In ◽

Sung-Do Cho ◽

Eui-Sung Choi ◽

...

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Knee Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

A Cell ◽

Cell And Gene Therapy

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study

Epilepsia ◽

10.1111/j.1528-1167.2008.01946.x ◽

2009 ◽

Vol 50 (3) ◽

pp. 454-463 ◽

Cited By ~ 164

Author(s):

Christian Elger ◽

Peter Halász ◽

Joana Maia ◽

Luis Almeida ◽

Patrício Soares-da-Silva ◽

...

Keyword(s):

Phase Iii ◽

Adjunctive Treatment ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Phase Iii Study